Following a thorough safety review, the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined that the recommended pause regarding the use of the Johnson & Johnson (Janssen) COVID-19 Vaccine in the U.S. should be lifted.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3sMcwof
No comments:
Post a Comment